Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2016, Article ID 4097471, 9 pages
http://dx.doi.org/10.1155/2016/4097471
Clinical Study

The Modification Effect of Influenza Vaccine on Prognostic Indicators for Cardiovascular Events after Acute Coronary Syndrome: Observations from an Influenza Vaccination Trial

1Ph.D. Program in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
2Department of Pharmacy Practice, School of Pharmaceutical Sciences, University of Phayao, Phayao 56000, Thailand
3Cardiology Division, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand
4Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand
5Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand

Received 9 March 2016; Accepted 29 March 2016

Academic Editor: Mariantonietta Cicoira

Copyright © 2016 Apirak Sribhutorn et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. C. G. Voordouw, P. D. van der Linden, S. Simonian, J. van der Lei, M. C. J. M. Sturkenboom, and B. H. C. Stricker, “Influenza vaccination in community-dwelling elderly,” Archives of Internal Medicine, vol. 163, no. 9, pp. 1089–1094, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Praditsuwan, P. Assantachai, C. Wasi, P. Puthavatana, and U. Kositanont, “The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community,” Journal of the Medical Association of Thailand, vol. 88, no. 2, pp. 256–264, 2005. View at Google Scholar · View at Scopus
  3. T. Jefferson, D. Rivetti, A. Rivetti, M. Rudin, C. Di Pietrantonj, and V. Demicheli, “Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review,” The Lancet, vol. 366, no. 9492, pp. 1165–1174, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Nordin, J. Mullooly, S. Poblete et al., “Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans,” Journal of Infectious Diseases, vol. 184, no. 6, pp. 665–670, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Jefferson, C. Di Pietrantonj, L. A. Al-Ansary, E. Ferroni, S. Thorning, and R. E. Thomas, “Vaccines for preventing influenza in the elderly,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD004876, 2010. View at Publisher · View at Google Scholar
  6. K. L. Nichol, J. D. Nordin, D. B. Nelson, J. P. Mullooly, and E. Hak, “Effectiveness of influenza vaccine in the community-dwelling elderly,” The New England Journal of Medicine, vol. 357, no. 14, pp. 1373–1381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. L. Nichol, J. Nordin, J. Mullooly, R. Lask, K. Fillbrandt, and M. Iwane, “Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly,” The New England Journal of Medicine, vol. 348, no. 14, pp. 1322–1332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Vila-Córcoles, T. Rodriguez, C. de Diego et al., “Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002–2005 influenza periods,” Vaccine, vol. 25, no. 37-38, pp. 6699–6707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Phrommintikul, S. Kuanprasert, W. Wongcharoen, R. Kanjanavanit, R. Chaiwarith, and A. Sukonthasarn, “Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome,” European Heart Journal, vol. 32, no. 14, pp. 1730–1735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. A. Udell, R. Zawi, D. L. Bhatt et al., “Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis,” The Journal of the American Medical Association, vol. 310, no. 16, pp. 1711–1720, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. E. P. Gurfinkel, R. L. De La Fuente, O. Mendiz, and B. Mautner, “Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) study,” Circulation, vol. 105, no. 18, pp. 2143–2147, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Gurfinkel, “Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study One-year follow-up,” European Heart Journal, vol. 25, no. 1, pp. 25–31, 2004. View at Google Scholar
  13. A. Ciszewski, Z. T. Bilinska, L. B. Brydak et al., “Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study,” European Heart Journal, vol. 29, no. 11, pp. 1350–1358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. M. Davis, K. Taubert, A. L. Benin et al., “Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology,” Journal of the American College of Cardiology, vol. 48, no. 7, pp. 1498–1502, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. C. Smith, E. J. Benjamin, R. O. Bonow et al., “AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation,” Circulation, vol. 124, no. 22, pp. 2458–2473, 2011. View at Publisher · View at Google Scholar
  16. P. T. O'Gara, F. G. Kushner, D. D. Ascheim et al., “2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Journal of the American College of Cardiology, vol. 61, no. 4, pp. e78–e140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. R. S. Wright, J. L. Anderson, C. D. Adams et al., “2012 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable Angina/Non–ST-elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 61, no. 23, pp. e179–e347, 2013. View at Google Scholar · View at Scopus
  18. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 ACCF/AHA guideline for the management of heart failure: a report of the american college of cardiology foundation/american heart association task force on practice guidelines,” Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Scharpé, W. E. Peetermans, J. Vanwalleghem et al., “Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial,” American Journal of Kidney Diseases, vol. 54, no. 1, pp. 77–85, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. K. A. Birdwell, M. R. Ikizler, E. C. Sannella et al., “Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study,” American Journal of Kidney Diseases, vol. 54, no. 1, pp. 112–121, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. M. J. C. Salles, Y. A. S. Sens, L. S. V. Boas, and C. M. Machado, “Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs,” Clinical Transplantation, vol. 24, no. 1, pp. E17–E23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Cavdar, M. Sayan, A. Sifil et al., “The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients,” Scandinavian Journal of Urology and Nephrology, vol. 37, no. 1, pp. 71–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Dvorakova and R. Poledne, “Influenza—a trigger for acute myocardial infarction,” Atherosclerosis, vol. 172, no. 2, p. 391, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells, “Influenza and cardiovascular disease: a new opportunity for prevention and the need for further studies,” Circulation, vol. 108, no. 22, pp. 2730–2736, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Naghavi, P. Wyde, S. Litovsky et al., “Influenza infection exerts prominent inflammatory and thrombotic effects on the atherosclerotic plaques of apolipoprotein E-deficient mice,” Circulation, vol. 107, no. 5, pp. 762–768, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. S. E. Epstein, J. Zhu, A. H. Najafi, and M. S. Burnett, “Insights into the role of infection in atherogenesis and in plaque rupture,” Circulation, vol. 119, no. 24, pp. 3133–3141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Haidari, P. R. Wyde, S. Litovsky et al., “Influenza virus directly infects, inflames, and resides in the arteries of atherosclerotic and normal mice,” Atherosclerosis, vol. 208, no. 1, pp. 90–96, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. F. Corrales-Medina, M. Madjid, and D. M. Musher, “Role of acute infection in triggering acute coronary syndromes,” The Lancet Infectious Diseases, vol. 10, no. 2, pp. 83–92, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Warren-Gash, L. Smeeth, and A. C. Hayward, “Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review,” The Lancet Infectious Diseases, vol. 9, no. 10, pp. 601–610, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Brame, P. Mazerolle, and A. Piquero, “Using the correct statistical test for the equality of regression coefficients,” Criminology, vol. 36, no. 4, pp. 859–866, 1998. View at Google Scholar
  31. O. Vardeny, J. J. M. Moran, N. K. Sweitzer, M. R. Johnson, and M. S. Hayney, “Decreased T-cell responses to influenza vaccination in patients with heart failure,” Pharmacotherapy, vol. 30, no. 1, pp. 10–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. C. M. Albrecht, N. K. Sweitzer, M. R. Johnson, and O. Vardeny, “Lack of persistence of influenza vaccine antibody titers in patients with heart failure,” Journal of Cardiac Failure, vol. 20, no. 2, pp. 105–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  33. O. Vardeny, N. K. Sweitzer, M. A. Detry, J. M. Moran, M. R. Johnson, and M. S. Hayney, “Decreased immune responses to influenza vaccination in patients with heart failure,” Journal of Cardiac Failure, vol. 15, no. 4, pp. 368–373, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. K. Grebe, K. Takeda, H. D. Hickman et al., “Cutting edge: sympathetic nervous system increases proinflammatory cytokines and exacerbates influenza A virus pathogenesis,” Journal of Immunology, vol. 184, no. 2, pp. 540–544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. K. M. Grebe, H. D. Hickman, K. R. Irvine, K. Takeda, J. R. Bennink, and J. W. Yewdell, “Sympathetic nervous system control of anti-influenza CD8+ T cell responses,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 13, pp. 5300–5305, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. J. McMichael, F. M. Gotch, G. R. Noble, and P. A. S. Beare, “Cytotoxic T-cell immunity to influenza,” The New England Journal of Medicine, vol. 309, no. 1, pp. 13–17, 1983. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Montminy, “Transcriptional regulation by cyclic AMP,” Annual Review of Biochemistry, vol. 66, pp. 807–822, 1997. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Kanemi, X. Zhang, Y. Sakamoto, M. Ebina, and R. Nagatomi, “Acute stress reduces intraparenchymal lung natural killer cells via beta-adrenergic stimulation,” Clinical and Experimental Immunology, vol. 139, no. 1, pp. 25–34, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Rudiger, “Beta-block the septic heart,” Critical Care Medicine, vol. 38, no. 10, pp. S608–S612, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. López-Sendón, K. Swedberg, and J. McMurray, “Expert consensus document on beta-adrenergic receptor blockers,” European Heart Journal, vol. 25, no. 15, pp. 1341–1362, 2004. View at Publisher · View at Google Scholar
  41. J. J. V. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 33, no. 14, pp. 1787–1847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. C. W. Hamm, J.-P. Bassand, S. Agewall et al., “ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevatio,” European Heart Journal, vol. 32, no. 23, pp. 2999–3054, 2011. View at Publisher · View at Google Scholar
  43. I. J. Elenkov, R. L. Wilder, G. P. Chrousos, and E. S. Vizi, “The sympathetic nerve—an integrative interface between two supersystems: the brain and the immune system,” Pharmacological Reviews, vol. 52, no. 4, pp. 595–638, 2000. View at Google Scholar · View at Scopus